ACTAVIS LLC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?
ACTAVIS LLC has eight approved drugs.
There is one tentative approval on ACTAVIS LLC drugs.
Summary for ACTAVIS LLC
US Patents: | 0 |
Tradenames: | 6 |
Ingredients: | 6 |
NDAs: | 8 |
PTAB Cases with ACTAVIS LLC as petitioner: | See PTAB cases with ACTAVIS LLC as petitioner |
Drugs and US Patents for ACTAVIS LLC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Llc | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 206018-001 | Dec 19, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Llc | AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 208216-001 | Apr 29, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Llc | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | POWDER;INTRAVENOUS | 206516-001 | Feb 13, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Llc | METHYLNALTREXONE BROMIDE | methylnaltrexone bromide | SOLUTION;SUBCUTANEOUS | 208112-001 | Aug 26, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Llc | DAPSONE | dapsone | TABLET;ORAL | 204380-001 | Mar 23, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Llc | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | POWDER;INTRAVENOUS | 208723-001 | Sep 29, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.